• Binnie, C. D., Debets, R. M. C., Engelsman, M., Meijer, J. W. A., Meinardi, H., Overweg, J., Peck, A. W., van Wieringen, A. & Yuen, W. C. (1989). Double-blind crossover trial of lamotrigine (Lamictal) as add-on therapy in intractable epilepsy. Epilepsy Res., 4, 222229.
  • Binnie, C. D., van Boas, Emde W., Kastelijn-Nolste-Trenite, D. G. A., de Korte, R. A., Meijer, J. W. A., Meinardi, H., Miller, A. A., Overweg, J., Peck, A. W., van Wieringen, A. & Yuen, W. C. (1986). Acute effects of lamotrigine (BW430C) in persons with epilepsy. Epilepsia, 27, 248254.
  • Chapman, A. A., Keane, P. E., Meldrum, B. S., Simiand, J. & Vernieres, J. C. (1982). Mechanism of anticonvulsant action of valproate. In Progress in Neurobiology, 19, 315359.
  • Cohen, A. F., Land, G. S., Breimer, D. D., Yuen, W. C., Winton, C. & Peck, A. W. (1987). Lamotrigine, a new anticonvulsant: Pharmacokinetics in normal humans. Clin. Pharmac. Ther., 42, 535541.
  • de Miranda, P., Good, S. S., Yarchoan, R., Thomas, R. V., Blum, M. R., Myers, C. E. & Broder, S. (1989). Alteration of zidovudine pharmacokinetics by probenecid in patients with Aids or Aids related complex. Clin. Pharmac. Ther., 46, 494500.
  • Depot, M., Powell, J. R., Messenheimer, J. A., Cloutier, G. & Dalton, M. J. (1990). Kinetic effects of multiple oral doses of acetaminophen on a single oral dose of lamotrigine. Clin. Pharmac. Ther., 48, 346355.
  • Howell, S. R., Hazelton, G. A. & Klaassen, C. D. (1986). Depletion of hepatic UDP-glucuronic acid by drugs that are glucuronidated. J. Pharmac. exp. Ther., 236, 610614.
  • Jawad, S., Richens, A., Goodwin, G. & Yuen, W. C. (1989). Controlled trial of lamotrigine (Lamictal®) for refractory partial seizures. Epilepsia, 30, 356363.
  • Loiseau, P., Yuen, A. W. C., Duche, B., Menager, T. & Arne-Bes, M. C. (1990). A randomised double-blind placebo-controlled crossover add-on trial of lamotrigine in patients with treatment-resistant partial seizures. Epilepsy Res., 7, 136145.
  • Metzler, C. M., Elfring, G. L. & McEwan, A. J. (1974). A package of computer programs for pharmacokinetic modelling. Biometrics, 30, 562563.
  • Miller, A. A., Wheatley, P., Sawyer, D. A., Baxter, M. G. & Roth, B. (1986). Pharmacological studies on lamotrigine, a novel potential antiepileptic drug: I. anticonvulsant profile in mice and rats. Epilepsia, 27, 483489.
  • Posner, J., Cohen, A. F., Land, G., Winton, C. & Peck, A. W. (1989). The pharmacokinetics of lamotrigine (BW430C) in healthy subjects with unconjugated hyperbilirubinaemia (Gilbert's Syndrome). Br. J. clin. Pharmac., 28, 117120.
  • Sander, J. W. A. S., Patsalos, P. N., Oxley, J. R., Hamilton, M. J. & Yuen, W. C. (1990). A randomised double-blind placebo-controlled add-on trial of lamotrigine in patients with severe epilepsy. Epilepsy Res., 6, 221226.
  • Sim, S. M., Back, D. J. & Breckenridge, A. M. (1991). The effect of various drugs on the glucuronidation of zidovudine (azidothymidine; AZT) by human liver microsomes. Br. J. clin. Pharmac., 32, 1721.
  • Yuen, W. C. & Peck, A. W. (1988). Lamotrigine pharmacokinetics: oral and i.v. infusion in man. Br. J. clin. Pharmac., 26, 242P.